U.S. Digital Therapeutics Market is Projected to Attain USD 5.08 Billion by 2027

According to a new report published by Allied Market Research, titled, the U.S. digital therapeutics market size was valued at $1.16 billion in 2019, and is expected to reach $5.08 billion by 2027 with a CAGR of 19.2% during the forecast period.

Digital Therapeutics (DTX) is a subset of digital health and not all digital health measures are digital therapeutics. The difference between digital health and digital therapy is based on the clinical outcomes of patients. For example, digital therapies do not include consumer health-focused technologies such as step-counter and calorie-counter.

𝑬𝒙𝒑𝒍𝒐𝒓𝒆 𝑴𝒐𝒓𝒆 𝑰𝒏𝒔𝒊𝒈𝒉𝒕𝒔@ https://www.alliedmarketresearch.com/request-sample/7066

It is a new class of healthcare products that use digital technology to prevent, manage or treat medical conditions. Additionally, it uses digital health technology to treat mental conditions. Hence, the aforementioned factors drive the growth of the US digital therapeutics market.

The US digital therapeutics market is expected to be positively impacted by the Covid-19 pandemic, increasing awareness of the importance of digital health, rising rates of mental illness, and increasing drug abuse in the country. Moreover, during this pandemic, people have to stay at home, which leads to less physical activity, unhealthy lifestyles, mental stress and the spread of chronic diseases. Hence, the demand for digital therapeutics (DTX) equipment and software is increasing across the country.

Demand for this specialty has grown significantly as a result of the growing demand for smartphones, tablets and smart wearables, including healthcare apps, the need to control healthcare costs and the prevalence of chronic diseases. In addition, the adoption of advanced technology and the growth of technology-driven healthcare products and applications further drives the market. However, the lack of reimbursement strategies for digital therapeutics and the issue of privacy of patient data hinder the growth of the market. Conversely, laws and regulations favorable to digital health technologies and increased investment in digital therapeutics are expected to provide significant lucrative opportunities for manufacturers in the US digital therapeutics market.

𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐄𝐧𝐪𝐮𝐢𝐫𝐲 https://www.alliedmarketresearch.com/purchase-enquiry/7066

𝐊𝐞𝐲 𝐀𝐝𝐯𝐚𝐧𝐭𝐚𝐠𝐞𝐬:

• Quantitative analysis of the current U.S. digital therapeutics market trends and forecast estimations from 2020 to 2027, which assists to identify the prevailing market opportunities.

• An in-depth market analysis includes analysis of various regions, which is anticipated to provide a detailed understanding of the current trends to enable stakeholders formulate country-specific plans.

• A comprehensive analysis of factors that drive and restrain growth of the market is provided.

• Country-wise market conditions are comprehensively analyzed in this report.

• The projections in this report are made by analyzing the current trends and future market potential from 2020 to 2027, in terms of value.

• An extensive analysis of the market provides insights that are expected to allow companies to strategically plan their business moves.

• Key market players within the U.S. digital therapeutics market are profiled in this report and their strategies are analyzed thoroughly, which helps in understanding competitive outlook of the market.

𝐊𝐞𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐏𝐥𝐚𝐲𝐞𝐫𝐬

• 2morrow, Inc.

• Fitbit, Inc. (Twine Health, Inc.)

• Livongo Health, Inc.

• Medtronic Plc.

• Pear Therapeutics, Inc.

• Omada Health, Inc.

• Proteus Digital Health, Inc.

• Resmed, Inc. (Propeller Health)

• Voluntis, Inc.

• Welldoc, Inc.

𝐊𝐧𝐨𝐰 𝐌𝐨𝐫𝐞- https://www.alliedmarketresearch.com/us-digital-therapeutics-market-A06701

𝐎𝐭𝐡𝐞𝐫 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐢𝐧 𝐋𝐢𝐟𝐞 𝐒𝐜𝐢𝐞𝐧𝐜𝐞 𝐃𝐨𝐦𝐚𝐢𝐧
𝐈𝐧𝐟𝐥𝐮𝐞𝐧𝐳𝐚 𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐌𝐚𝐫𝐤𝐞𝐭 https://www.alliedmarketresearch.com/influenza-treatment-market-A06106

𝐒𝐭𝐞𝐫𝐢𝐥𝐢𝐳𝐚𝐭𝐢𝐨𝐧 𝐒𝐞𝐫𝐯𝐢𝐜𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 https://www.alliedmarketresearch.com/sterilization-services-market-A07513

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
Web: https://www.alliedmarketresearch.com

Alied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

This release was published on openPR.